Analysis of Carrier-Mediated Transport Systems in Drug Absorption from Oral Mucosa

口腔粘膜药物吸收中载体介导的转运系统分析

基本信息

  • 批准号:
    10672041
  • 负责人:
  • 金额:
    $ 2.05万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

The in vitro uptake study was performed using the isolated cells of human oral mucosa, buccal and the dorsum of tongue, to investigate the mechanisms of glucose and oligopeptide uptake. The uptake of D-glucose was much larger in cells of the dorsum of tongue than in buccal cells and was inhibited more extensively by 2-deoxy-D-glucose, a substrate of facilitative glucose transporters, than by α-methyl-D-glucoside, a specific substrate of SGLT1, suggesting the larger contribution of facilitative transporter than NaィイD1+ィエD1/glucose cotransporter. Furthermore, from the results of inhibition studies by the several sugar analogues including maltose and D-mannose, GLUT1 and/or GLUT3 were suggested to take part in the glucose uptake by oral mucosa. Therefore, we have attempted to confirm the expression of glucose transporters on the oral mucosa by employing Western blotting. As a result, it was suggested that SGLT1, GLUT1, GLUT2 and GLUT3 are expressed in the epithelial cells of human oral mucosa. The result of the uptake study of glycylsarcosine, a model dipeptide, by isolated oral cells showed the presence of carrier-mediated transport systems for oligopeptides in human oral mucosal cells. The transport of D-glucose and glycylsarcosine across stratified cell layer of cultured human oral mucosal cells was also examined, and the results showed that the transporters function not only for the uptake of these substrates by the mucosal cells but also for the transport across the stratified mucosal cell layers.
利用人口腔粘膜、颊部和舌背的分离细胞进行体外摄取研究,以探讨葡萄糖和寡肽的摄取机制。舌背细胞对 D-葡萄糖的摄取量比颊细胞大得多,并且与 SGLT1 的特异性底物 α-甲基-D-葡萄糖苷相比,促进葡萄糖转运蛋白的底物 2-脱氧-D-葡萄糖对 D-葡萄糖的抑制更广泛,这表明促进转运蛋白的贡献比颊细胞更大。 NaィイD1+ィエD1/葡萄糖协同转运蛋白。此外,根据包括麦芽糖和D-甘露糖在内的几种糖类似物的抑制研究结果,表明GLUT1和/或GLUT3参与口腔粘膜的葡萄糖摄取。因此,我们尝试通过蛋白质印迹法确认口腔粘膜上葡萄糖转运蛋白的表达。结果表明,SGLT1、GLUT1、GLUT2和GLUT3在人口腔粘膜上皮细胞中表达。分离的口腔细胞对甘氨酰肌氨酸(一种模型二肽)的摄取研究结果表明,人口腔粘膜细胞中存在载体介导的寡肽转运系统。还检查了 D-葡萄糖和甘氨酰肌氨酸穿过培养的人口腔粘膜细胞的分层细胞层的转运,结果表明转运蛋白不仅具有粘膜细胞摄取这些底物的功能,而且还具有穿过分层粘膜细胞层的转运功能。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yujiro Oyama: "Carrier-Mediated Transport Systems for Glucose in Mucosal cells of the Human Oral Cavity"Journal of Pharmaceutical Science. 88・8. 830-834 (1999)
Yujiro Oyama:“人体口腔粘膜细胞中葡萄糖的载体介导的运输系统”《药物科学杂志》88・8(1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yujiro Oyama, Hitoshi Yamano, Akiko Ohkuma, Ken-ichi Ogawara, Kazutaka Higaki, and Toshikiro Kimura :: "Carrier-mediated Transport Systems for Glucose in Mucosal Cells of Human Oral Cavity"Journal of Pharmaceutical Sciences. 88・8. 830-834 (1999)
Yujiro Oyama、Hitoshi Yamano、Akiko Ohkuma、Ken-ichi Okawara、Kazutaka Higaki 和 Toshikiro Kimura ::“人体口腔粘膜细胞中葡萄糖的载体介导的运输系统”药物科学杂志 830-834。 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yujiro Oyama: "Carrier-Mediated Transport Systems for Glucose in Mucosal cells of the Human Oral Cavity"Journal of Pharmaceutical Sciences. 88・8. 830-834 (1999)
Yujiro Oyama:“人类口腔粘膜细胞中的载体介导的葡萄糖转运系统”《药物科学杂志》88・8(1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIMURA Toshikiro其他文献

KIMURA Toshikiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIMURA Toshikiro', 18)}}的其他基金

Analysis of dissolution kinetics and first-pass elimination of orally administered drugs and its application to prediction of absorption behavior after oral administration
口服药物溶出动力学和首过消除分析及其在预测口服后吸收行为中的应用
  • 批准号:
    21590158
  • 财政年份:
    2009
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of first-pass effect in small intestinal mucosa and its application to prediction of drug absorption behavior after oral administration
小肠黏膜首过效应分析及其在预测口服药物吸收行为中的应用
  • 批准号:
    19590144
  • 财政年份:
    2007
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of physiological factors regulating oral absorption behaviors of drugs and its application to prediction of plasma concentration-time profile
药物口服吸收行为生理因素分析及其在血药浓度-时间曲线预测中的应用
  • 批准号:
    17590124
  • 财政年份:
    2005
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Drug Permeation Mechanism across Oral Mucosa Using Cultured Stratified Cell Layers
使用培养的分层细胞层分析药物在口腔粘膜的渗透机制
  • 批准号:
    15590131
  • 财政年份:
    2003
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Experimental Analysis of Anomalous Pharmacokinetics in Disease State: Pharmacokinetics in Diabetes
疾病状态下异常药代动力学的实验分析:糖尿病的药代动力学
  • 批准号:
    63571097
  • 财政年份:
    1988
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Development and Translation of D-glucose as a Diagnostic Agent for MRI of Cancer
D-葡萄糖作为癌症 MRI 诊断剂的开发和转化
  • 批准号:
    10732247
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis
D-葡萄糖作为多发性硬化症 MRI 造影剂的开发和转化
  • 批准号:
    10247299
  • 财政年份:
    2020
  • 资助金额:
    $ 2.05万
  • 项目类别:
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis
D-葡萄糖作为多发性硬化症 MRI 造影剂的开发和转化
  • 批准号:
    10457448
  • 财政年份:
    2020
  • 资助金额:
    $ 2.05万
  • 项目类别:
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis
D-葡萄糖作为多发性硬化症 MRI 造影剂的开发和转化
  • 批准号:
    10268261
  • 财政年份:
    2020
  • 资助金额:
    $ 2.05万
  • 项目类别:
Development of a colorimetric boronic acid-based chemosensor for determining D-glucose
开发用于测定 D-葡萄糖的比色硼酸化学传感器
  • 批准号:
    19J11173
  • 财政年份:
    2019
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of an anticancer therapy against liver cancer using 2-deoxy-D-glucose encapsulated in polymer poly (lactic-co-glycolic acid) nanoparticles
使用封装在聚合物聚(乳酸-乙醇酸)纳米颗粒中的 2-脱氧-D-葡萄糖开发针对肝癌的抗癌疗法
  • 批准号:
    18K07923
  • 财政年份:
    2018
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis
D-葡萄糖作为多发性硬化症 MRI 造影剂的开发和转化
  • 批准号:
    9527559
  • 财政年份:
    2018
  • 资助金额:
    $ 2.05万
  • 项目类别:
Development and Translation of D-glucose as a Diagnostic Agent for MRI of Cancer
D-葡萄糖作为癌症 MRI 诊断剂的开发和转化
  • 批准号:
    8854375
  • 财政年份:
    2015
  • 资助金额:
    $ 2.05万
  • 项目类别:
An enzymatic method for preparation of 6-membered carbocyclic compound from D-glucose
D-葡萄糖酶法制备六元碳环化合物
  • 批准号:
    24350078
  • 财政年份:
    2012
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Proteomics and functional analysis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells under simultaneous administration of 2-deoxy-D-glucose
同时给予2-脱氧-D-葡萄糖糖皮质激素诱导淋巴细胞白血病细胞凋亡的蛋白质组学和功能分析
  • 批准号:
    201482994
  • 财政年份:
    2011
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Clinical Research Units
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了